OssDsign’s year-end results to be presented via webcast
OssDsign AB (publ) (“OssDsign” or the “Company”) will present their upcoming year-end report live via Finwire TV Webcast
OssDsign will be publishing the year-end report 2020 tomorrow Thursday February 11th at 08:00 CET. Later tomorrow, the results will also be presented live by CEO Morten Henneveld via a webcast in cooperation with Finwire Media. The webcast, which will run from 10:00 CET tomorrow February 11th, can be followed via the link https://www.finwire.tv/webcast/ossdsign/q4/ where it also will be possible to submit questions.
For further information, please contact:
Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com
Certified Adviser:
Erik Penser Bank AB is the company’s Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email: certifiedadviser@penser.se.
About OssDsign
OssDsign is a Swedish medical technology company that develops and manufactures regenerative implant solutions for bone and tissue restoration. Providing neuro- and plastic surgeons with innovative solutions, OssDsign improves the outcome for patients worldwide. By combining clinical knowledge with proprietary technology, OssDsign works closely with surgeons to provide patients with personalized bone tissue restoration solutions. OssDsign's technology is the result of collaboration between clinical researchers at Karolinska University Hospital in Stockholm and material scientists at the Ångström Laboratory at Uppsala University. OssDsign recently expanded its operations into the Orthobiologic space via the acquisition of Scotland based Sirakoss Ltd.
Tags: